SCHEMBL1219448

SCHEMBL1219448

CC(C)(C)/C(=C\C(=O)O)c1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
CASP1 P29466 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
ALDH1A1 P00352 4/20 0.49
MAPT P10636 3/20 0.49
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
SRD5A2 P31213 1/20 0.45
POLB P06746 3/20 0.43
THRB P10828 1/20 0.43
RECQL P46063 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16738481 0.80 HSP90AA1 (0.41) TSHRCASP1SMN1; SMN2HPGDNR1H4
Hydrochloric Acid SCHEMBL6900887 0.79 TSHR (0.58) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL20832360 0.79 MEN1 (0.47) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL12532565 0.77 SMN1; SMN2 (0.59) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL16738521 0.74 ALDH1A1 (0.34) ALDH1A1POLBRECQLTDP1L3MBTL1
SCHEMBL14034212 0.73 PARP1 (0.49) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL11231466 0.72 ALDH1A1 (0.69) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL11231463 0.72 ALDH1A1 (0.69) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL2461313 0.72 SMN1; SMN2 (0.53) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL107060 0.72 SMN1; SMN2 (0.68) TSHRCASP1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893096-B2 For example, N-methyl-4-[(2-{[2-(1-methylethyl)phenyl]amino}-1 H-benzimidazol-5-yl)oxy]pyridine-2-carboxamide; administering the compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2011-02-22 US disclosed